Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New System for Treating Cartilage Lesions

By HospiMedica staff writers
Posted on 29 Aug 2006
A cartilage surface implant system is designed for the treatment of patello-femoral disease, localized cartilage lesions, and defects in the major joints.

The HemiCAP (contoured articular prosthetic) resurfacing system replaces damaged cartilage surfaces with contoured implants that are matched to the patients' anatomy using a patented, intra-operative, three dimensional (3D) mapping technology. More...
The system is comprised of three elements: the 3D mapping technology, a set of instruments to map and prepare the damaged area, and an off-the-shelf rounded, cap-like implant made from a cobalt chrome alloy with a central post on the implanted (bone) side. The system can be used for various knee, shoulder, hip, and great toe applications.

The surgical procedure begins the same way as all arthroscopic procedures. Through a small access incision an arthroscope is inserted into a cannula, which is used to protect it and also allow for saline fluid to flow into the joint. Through another incision, different instruments are inserted for use during the operation. When an articular defect is confirmed, the central axis in the middle of the defect is located and a component that looks like a screw is implanted to establish the mechanism for anchoring the resurfacing implant. Using this first component as a central axis, several specially designed instruments are introduced to map the contours of the patient's articular cartilage surrounding the defect and to prepare the tissue in and around the defect itself for the resurfacing implant. Once the site is prepared, the HemiCAP resurfacing implant is brought into position and seated.

The HemiCAP system is intended to provide an effective interim means for managing pain and disability in middle-aged patients until a total joint-replacement treatment option becomes more necessary, and is part of a clinical treatment strategy to help avoid early-age-revision scenarios. The prosthetic may also provide a treatment option for the older patient who may not tolerate the morbidity of a total joint-replacement procedure. The implants and instruments are designed to remove a minimal amount of bone stock, preserve functional structures and tissues, and allow for an uncomplicated removal in the event of revision.

"The principal advantage of the Arthrosurface system is that it is an intuitive technology that allows for very accurate matching of the implants to the affected cartilage surface, without altering the biomechanics of the joint,” said Dr. Anthony Schepsis of the Boston University Medical Center (MA, USA).

The HemiCAP system was developed by Arthrosurface (Franklin, MA, USA) and is available in the United States, Europe, Australasia, Latin America, and South Africa.



Related Links:
Arthrosurface

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.